Literature DB >> 11532423

Is a proliferation index of cancer cells a reliable prognostic factor after hepatectomy in patients with colorectal liver metastases?

J C Weber1, H Nakano, P Bachellier, E Oussoultzoglou, K Inoue, H Shimura, P Wolf, M P Chenard-Neu, D Jaeck.   

Abstract

BACKGROUND: In spite of many reports focusing on prognostic factors after hepatectomy in patients with colorectal liver metastases, few studies have investigated pathological factors, eg, fibrous pseudocapsulation, growth pattern at the tumor margin, and proliferation activity of cancer cells, other than histological type and surgical margin. The aim of the present study was to investigate whether absence of pseudocapsulation, infiltrative growth pattern of metastases, and higher proliferation of cancer cells shown by Ki-67 immunohistochemical reactivity were associated with poorer survival after hepatectomy among patients with colorectal liver metastases.
METHODS: Between 1988 and 1998, 221 patients underwent hepatic resection of colorectal metastases with curative intent in our institution. Pathology analyses were focused on pseudocapsulation of liver metastases, growth pattern at the tumor edge, and Ki-67 labelling index (Ki-67 LI) of cancer cell nuclei. Univariate analyses of survival and of disease-free survival were performed for several clinicopathological factors, and multivariate analyses of survival and disease-free survival were also performed.
RESULTS: The univariate survival analyses showed that pseudocapsulation, growth pattern, and Ki-67 LI were significant prognostic factors, besides synchronous versus metachronous occurrence of metastases, carcinoembryonic antigen level before hepatectomy, and number of metastases. A multivariate analysis showed that Ki-67 labeling index was the most reliable prognostic factor of survival. In addition, Ki-67 LI and microscopic growth pattern were multivariately predictive factors of disease-free survival.
CONCLUSIONS: This large single-institution study showed that investigation of cancer cell proliferation and pathologic characteristics of the tumor margin are major prognostic factors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11532423     DOI: 10.1016/s0002-9610(01)00656-0

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  22 in total

1.  Invasion pattern and histologic features of tumor aggressiveness correlate with MMR protein expression, but are independent of activating KRAS and BRAF mutations in CRC.

Authors:  Konrad Steinestel; Jochen K Lennerz; Stefan Eder; Klaus Kraft; Annette Arndt
Journal:  Virchows Arch       Date:  2014-06-12       Impact factor: 4.064

2.  Colorectal Cancer Liver Metastases: Biopsy of the Ablation Zone and Margins Can Be Used to Predict Oncologic Outcome.

Authors:  Vlasios S Sotirchos; Lydia M Petrovic; Mithat Gönen; David S Klimstra; Richard K G Do; Elena N Petre; Alessandra R Garcia; Afsar Barlas; Joseph P Erinjeri; Karen T Brown; Anne M Covey; William Alago; Lynn A Brody; Ronald P DeMatteo; Nancy E Kemeny; Stephen B Solomon; Katia O Manova-Todorova; Constantinos T Sofocleous
Journal:  Radiology       Date:  2016-03-24       Impact factor: 11.105

Review 3.  Shifting from clinical to biologic indicators of prognosis after resection of hepatic colorectal metastases.

Authors:  Timothy M Pawlik; Michael A Choti
Journal:  Curr Oncol Rep       Date:  2007-05       Impact factor: 5.075

4.  Prognostic factors in 165 elderly colorectal cancer patients.

Authors:  Ke-Jun Nan; Hai-Xia Qin; Guang Yang
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

Review 5.  Surgery for colorectal liver metastases: The evolution of determining prognosis.

Authors:  Gaya Spolverato; Aslam Ejaz; Nilo Azad; Timothy M Pawlik
Journal:  World J Gastrointest Oncol       Date:  2013-12-15

6.  Contrast-enhanced intraoperative ultrasonography equipped with late Kupffer-phase image obtained by sonazoid in patients with colorectal liver metastases.

Authors:  Hiroshi Nakano; Yasuo Ishida; Toshiyuki Hatakeyama; Kazuma Sakuraba; Masahiro Hayashi; Osamu Sakurai; Kiyoshi Hataya
Journal:  World J Gastroenterol       Date:  2008-05-28       Impact factor: 5.742

7.  Can we improve the clinical risk score? The prognostic value of p53, Ki-67 and thymidylate synthase in patients undergoing radical resection of colorectal liver metastases.

Authors:  Arpad Ivanecz; Rajko Kavalar; Miroslav Palfy; Vid Pivec; Marko Sremec; Matjaž Horvat; Stojan Potrč
Journal:  HPB (Oxford)       Date:  2013-03-19       Impact factor: 3.647

8.  Metastatic tumor doubling time: most important prehepatectomy predictor of survival and nonrecurrence of hepatic colorectal cancer metastasis.

Authors:  Kuniya Tanaka; Hiroshi Shimada; Masaru Miura; Yoshiro Fujii; Shigeki Yamaguchi; Itaru Endo; Hitoshi Sekido; Shinji Togo; Hideyuki Ike
Journal:  World J Surg       Date:  2004-02-17       Impact factor: 3.352

Review 9.  Surgical therapy for colorectal metastases to the liver.

Authors:  Timothy M Pawlik; Michael A Choti
Journal:  J Gastrointest Surg       Date:  2007-08       Impact factor: 3.452

10.  Effect of portal vein embolisation on the growth rate of colorectal liver metastases.

Authors:  V Pamecha; A Levene; F Grillo; N Woodward; A Dhillon; B R Davidson
Journal:  Br J Cancer       Date:  2009-02-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.